Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

There’s nothing wrong with opening multiple brokerage accounts. In fact, it may be beneficial. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...

Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances. Lymph node-like ...

News-driven FX Trading: How to Trade Events Like the FOMC, CPI, and NFP US Dollar Index slips to 98.58 as retail sales plunge 0.9% and industrial production drops for a second time in three months.